Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. (KRTX) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 530 transactions totaling $683.5M, demonstrating a bearish sentiment with -$575.9M in net insider flow. The most recent transaction on Mar 18, 2024 involved a transaction of 36,117 shares valued at $11.9M.
KRTX Insider Activity Summary
Who Is Buying KRTX Stock?
No significant insider buying has been recorded for KRTX in the recent period.
Who Is Selling KRTX Stock?
No significant insider selling has been recorded for KRTX in the recent period.
Is Karuna Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KRTX is bearish with an Insider Alignment Score of 8/100 and a net flow of -$575.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KRTX Frequently Asked Questions
Understanding KRTX Insider Activity
Insider trading at Karuna Therapeutics, Inc. (KRTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading KRTX stock, having executed 530 transactions in the past 90 days. The most active insider is James Healy (Executive), who has made 29 transactions totaling $514.4M.
Related Tools
Track Karuna Therapeutics, Inc. Insider Activity
Get notified when executives and directors at KRTX file new Form 4 transactions